CLINICAL_TRIALS
trial_result
· 2013-08-14
Clinical Trial Update: Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 trial update reporting results for an intramuscular depot formulation of aripiprazole as maintenance treatment in schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-08-14